CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-22 | KAZIMI A J Chairman and CEO | Shares withheld for taxes | −46,623 | $5.62 | $262K | 5,759,274 |
| 2019-03-22 | Galante Joseph C Director | Grant or award | +1,000 | $5.98 | $6K | 8,350 |
| 2019-03-22 | Krogulski Kenneth Director | Grant or award | +1,000 | $5.98 | $6K | 156,300 |
| 2019-03-22 | Young Caroline Director | Grant or award | +1,000 | $5.98 | $6K | 4,000 |
| 2019-03-22 | Jones James Director | Grant or award | +1,000 | $5.98 | $6K | 12,700 |
| 2018-04-04 | Galante Joseph C Director | Purchase | +241 | $6.19 | $1K | 9,633 |
Page 201 of 201 · 4,006 trades